Home » Mylan Doesn't Have to Recall Already-Shipped Generic Precedex in 'Carve-Out' Row with Hospira
Mylan Doesn't Have to Recall Already-Shipped Generic Precedex in 'Carve-Out' Row with Hospira
A federal court has ruled that generic manufacturer Mylan does not have to recall its already-shipped versions of Hospira’s sedative Precedex, a move that reverses the court’s earlier mandate to recall all existing generic versions of the drug.
Drug Industry Daily
Upcoming Events
-
07May
-
14May
-
30May